BioCentury
ARTICLE | Company News

Management tracks

June 27, 2015 12:42 AM UTC

CNS company KemPharm Inc. (NASDAQ:KMPH) promoted LaDuane Clifton to CFO from VP of finance and corporate controller. He replaces Gordon Johnson, who became CBO.

Food allergy company DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT) named Hugh Sampson CSO, effective Nov. 1. Sampson is a professor of pediatrics and director of the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai (New York, N.Y.). ...